ReviewMediterranean journal of rheumatology2020

Therapeutic targeting of JAKs: from hematology to rheumatology and from the first to the second generation of JAK inhibitors.

George BertsiasPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.